Deborah Morosini is VP at Prelude Therapeutics Inc (PRLD). They have made 4 open-market trades across 1 company since 2020, most recently 2021-12-15.
CIK 0001824625
1 open-market purchase totalling $8K since 2020, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PRLD | 3,460 | $11K |
Shares reported on the most recent Form 4, priced at the 2021-12-17 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PRLD | SELL | 2021-12-15 | 2021-12-17 | $13.00 | $374K | -6.7% | -35.2% | -38.9% |
| PRLD | SELL | 2021-11-16 | 2021-11-18 | $15.87 | $906K | -3.1% | -6.3% | -28.3% |
| PRLD | SELL | 2021-04-29 | 2021-04-30 | $40.29 | $260K | +7.9% | -19.7% | -20.3% |
| PRLD | SELL · 10b5-1 | 2021-04-08 | 2021-04-15 | $40.00 | $4K | +5.2% | +23.6% | -23.7% |
| PRLD | SELL · 10b5-1 | 2021-04-07 | 2021-04-09 | $40.04 | $40K | +1.5% | +16.4% | -21.1% |
| PRLD | BUY | 2020-09-29 | 2020-09-29 | $19.00 | $8K | +53.5% | +22.5% | +195.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.